Hutch News

Hutch News

Stories tagged 'Chronic graft-versus-host disease'

Earlier detection for a deadly lung disease

'To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.'

March 25, 2019 | By Jake Siegel / Fred Hutch News Service

“To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.”

View story >


What’s new in combatting chronic graft-vs.-host disease

Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects

April 2, 2018 | By Rachel Tompa / Fred Hutch News Service

Up to 40% of transplant recipients develop chronic graft-vs.-host disease, which can last for years. But chronic GVHD is treatable, and new therapies and preventive measures are arriving and being tested in trials.

View story >


Stem cell transplantation physician-scientist recruited from Australia to join Fred Hutch, SCCA

Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies

Dec. 7, 2017 | By Molly McElroy

Fred Hutchinson Cancer Research Center is appointing world-renowned blood stem cell transplantation physician-scientist Dr. Geoffrey Hill to be director of Hematopoietic Stem Cell Transplantation, effective July 1.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.